Latest filing published 06 Mar 2026 for Quest Diagnostics INC, €260k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael J. Deppe (senior executive) discloses dealings in Quest Diagnostics Inc to SEC (Form 4). Between 18 May 2021 and 4 March 2026, the trades on record add up to 21 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 6 March 2026: a share grant of €260k, in Quest Diagnostics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations